fig9

Figure 9. Structures of small-molecule di/trimethoxyphenyl- and amide/peptide-based inhibitors (polypeptides were omitted for clarity) and repurposed drugs with inhibitory effects on MYB activity (green: mechanisms; red: targeted cancers).